CoChat

Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression

Kim, Jung H., Dhanasekaran, Saravana M., Mehra, Rohit, Tomlins, Scott A., Gu, Wenjuan, Yu, Jianjun, Kumar-Sinha, Chandan, Cao, Xuhong, Dash, Atreya, Wang, Lei, Ghosh, Debashis, Shedden, Kerby, Montie, James E., Rubin, Mark A., Pienta, Kenneth J., Shah, Rajal B., Chinnaiyan, Arul M. · 2007 · Cancer Research
Cited by 122

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Integrative analysis of genomic aberrations in the context of trancriptomic alterations will lead to a more comprehensive perspective on prostate cancer progression. Genome-wide copy number changes were monitored using array comparative genomic hybridization of laser-capture microdissected prostate cancer samples spanning stages of prostate cancer progression, including precursor lesions, clinically localized disease, and metastatic disease. A total of 62 specific cell populations from 38 patients were profiled. Minimal common regions (MCR) of alterations were defined for each sample type, and metastatic samples displayed the most number of alterations. Clinically localized prostate cancer samples with high Gleason grade resembled metastatic samples with respect to the size of altered regions and number of affected genes. A total of 9 out of 13 MCRs in the putative precursor lesion, high-grade prostatic intraepithelial neoplasia (PIN), showed an overlap with prostate cancer cases (amplifications in 3q29, 5q31.3-q32, 6q27, and 8q24.3 and deletions in 6q22.31, 16p12.2, 17q21.2, and 17q21.31), whereas postatrophic hyperplasia (PAH) did not exhibit this overlap. Interestingly, prostate cancers that do not overexpress ETS family members (i.e., gene fusion–negative prostate cancers) harbor differential aberrations in 1q23, 6q16, 6q21, 10q23, and 10q24. Integrative analysis with matched mRNA profiles identified genetic alterations in several proposed candidate genes implicated in prostate cancer progression. [Cancer Res 2007;67(17):8229–39]

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-07-1297

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 122

Metadata

Authors
Kim, J. H., Dhanasekaran, S. M., Mehra, R., Tomlins, S. A., Gu, W., Yu, J., Kumar-Sinha, C., Cao, X., Dash, A., Wang, L., Ghosh, D., Shedden, K., Montie, J. E., Rubin, M. A., Pienta, K. J., Shah, R. B., & Chinnaiyan, A. M.
Venue
Cancer Research
Published
2007-09-01
Volume
67
Issue
17
Pages
8229-8239
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2093889847
Cited by
122
References
4
FWCI
10.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression. https://app.cochat.ai/papers/10.1158/0008-5472.can-07-1297
The paper
Kim, J. H., Dhanasekaran, S. M., Mehra, R., Tomlins, S. A., Gu, W., Yu, J., Kumar-Sinha, C., Cao, X., Dash, A., Wang, L., Ghosh, D., Shedden, K., Montie, J. E., Rubin, M. A., Pienta, K. J., Shah, R. B., & Chinnaiyan, A. M. (2007). Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression. Cancer Research. https://doi.org/10.1158/0008-5472.can-07-1297

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.